- Home
- SPRY vs SA Comparison
SPRY vs SA Comparison
Compare SPRY & SA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPRY | SA |
|---|---|---|
| Founded | 2015 | 1979 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 833.1M | 2.8B |
| IPO Year | 2020 | 2004 |
Fundamental Metrics
Financial Performance| Metric | SPRY | SA |
|---|---|---|
| Price | $8.27 | $29.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $40.00 | ★ $65.00 |
| AVG Volume (30 Days) | ★ 1.5M | 784.0K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $84,278,000.00 | N/A |
| Revenue This Year | $87.40 | N/A |
| Revenue Next Year | $81.64 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.66 | $11.12 |
| 52 Week High | $18.63 | $40.06 |
Technical Indicators
Market Signals| Indicator | SPRY | SA |
|---|---|---|
| Relative Strength Index (RSI) | 50.94 | 46.10 |
| Support Level | $8.05 | $27.94 |
| Resistance Level | $8.63 | $31.91 |
| Average True Range (ATR) | 0.40 | 1.44 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 72.22 | 9.96 |
Price Performance
Historical ComparisonAbout SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
About SA Seabridge Gold Inc. (Canada)
Seabridge Gold Inc is a development stage company involved in the exploration and development of gold properties situated in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, the Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.